Tesamorelin Tesamorelin is an FDAapproved peptide for reducing visceral fat, particularly in HIVassociated lipodystrophy, and has robust clinical evidence behind it: Tesamorelin stimulates growth hormone release more effectively than AOD9604
Unreconstituted IGF-1 LR3 vials should be stored refrigerated at 28C in lyophilized powder form, protected from light
PMID: 39452684
Sumimoto K, Tanaka S, Shigita K, Hirano D, Tamaru Y, Ninomiya Y, Asayama N, Hayashi N, Oka S, Arihiro K, Yoshihara M, Chayama K (2017) Clinical impact and characteristics of the narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team